LXRX LEXICON PHARMACEUTICALS, INC.: institutional ownership and insider trading
163 funds reported holding $894M of LEXICON PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net bought $98.6M, with 43 new positions and 29 funds selling out; over the last 12 months insiders bought $2.72M and sold $0 on the open market.
Famous investors holding LXRX
- Ken Griffin (Citadel Advisors): $4.77M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $2.72M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.70M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.54M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $53.3K, 0.0% of the portfolio
Largest institutional holders of LXRX
- Artal Group S.A. — $420M
- FMR LLC — $124M
- Siren, L.L.C. — $106M
- Sessa Capital IM, L.P. — $45.5M
- BlackRock, Inc. (BLK) — $41.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $23.8M
- Point72 Asset Management, L.P. — $19.8M
- GEODE CAPITAL MANAGEMENT, LLC — $15.0M
- STATE STREET CORP (STT, STT-PG) — $11.8M
- VANGUARD GROUP INC — $11.0M
Recent LXRX insider trades
- Feb 25, 2026: Debbane Raymond bought 2,000 shares ($2.98K)
- Feb 23, 2026: Debbane Raymond bought 100,000 shares ($147K)
- Feb 20, 2026: Debbane Raymond bought 150,000 shares ($220K)
- Feb 18, 2026: Debbane Raymond bought 268,497 shares ($353K)
5%+ owners
- Artal Participations S.a r.l.: 39.4% (Schedule 13D/A, filed May 8, 2026)
- FMR LLC: 11.7% (Schedule 13G/A, filed Aug 6, 2026)